• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钕钇铝石榴石激光治疗局限性前列腺癌。

Neodymium-YAG laser in the treatment of localized prostate cancer.

作者信息

Beisland H O

机构信息

Department of Surgery and Urology, Aker University Hospital, Oslo, Norway.

出版信息

Ann Chir Gynaecol. 1990;79(4):200-2.

PMID:2102638
Abstract

The combination of transurethral resection and subsequent Neodymium-YAG laser irradiation has been practiced for radical treatment of localized prostate cancer since 1981. One hundred and eighteen patients have been treated and the observation time ranges 6-98 months. The treatment is performed endoscopically in two separate steps. The procedure is simple and complications are few. One hundred and four patients are evaluated as disease-free survivors. The overall actuarial disease-free survival rate is 88% in the 4-8 year period. The results compare satisfactorily with results obtained by other methods. Recently published results from other clinics confirm the laser to be promising in the treatment of localized prostate cancer.

摘要

自1981年以来,经尿道切除术联合随后的钕钇铝石榴石激光照射已被用于局部前列腺癌的根治性治疗。118例患者接受了治疗,观察时间为6至98个月。治疗通过内镜分两个独立步骤进行。该手术操作简单,并发症少。104例患者被评估为无病生存者。在4至8年期间,总体精算无病生存率为88%。结果与其他方法获得的结果相比令人满意。其他诊所最近发表的结果证实激光在局部前列腺癌的治疗中很有前景。

相似文献

1
Neodymium-YAG laser in the treatment of localized prostate cancer.钕钇铝石榴石激光治疗局限性前列腺癌。
Ann Chir Gynaecol. 1990;79(4):200-2.
2
Localized prostate carcinoma treated with TUR and neodymium-YAG laser irradiation.经尿道前列腺切除术(TUR)及钕钇铝石榴石激光照射治疗局限性前列腺癌
Scand J Urol Nephrol Suppl. 1991;138:117-9.
3
Neodymium-YAG laser in the treatment of localized prostatic cancer.钕钇铝石榴石激光治疗局限性前列腺癌
Acta Urol Belg. 1989;57(3):709-13.
4
Transurethral prostatic resection or laser therapy for men with acute urinary retention: the ClasP randomized trial.经尿道前列腺切除术或激光治疗男性急性尿潴留:ClasP随机试验
J Urol. 2001 Jul;166(1):166-70; discussion 170-1.
5
Long-term survival following radical prostatectomy in Japanese men with clinically localized prostate cancer: a single institutional study.
Int J Urol. 2004 Oct;11(10):862-9. doi: 10.1111/j.1442-2042.2004.00911.x.
6
Three-year results of treatment for prostate cancer with low-dose rate temporary iridium-192 brachytherapy.低剂量率临时铱-192近距离放射治疗前列腺癌的三年治疗结果
Int J Urol. 2006 Mar;13(3):218-23. doi: 10.1111/j.1442-2042.2006.01266.x.
7
[Treatment of prostatic tumors with interstitial thermocoagulation with neodymium-YAG (a new treatment in minimally invasive surgery)].钕钇铝石榴石间质热凝治疗前列腺肿瘤(微创手术中的一种新疗法)
Arch Esp Urol. 1993 May;46(4):317-9.
8
[Treatment of clinically localized prostatic cancer--endocrine therapy].[临床局限性前列腺癌的治疗——内分泌治疗]
Hinyokika Kiyo. 1996 Oct;42(10):829-32.
9
A randomized trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement: The CLasP study.一项比较经尿道前列腺切除术、激光治疗与对伴有良性前列腺增生相关症状男性进行保守治疗的随机试验:CLasP研究。
J Urol. 2000 Jul;164(1):65-70.
10
Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.临床局限性前列腺癌单纯根治性前列腺切除术后临床及病理因素与前列腺特异性抗原水平升高的相关性
Urology. 1996 Aug;48(2):249-60. doi: 10.1016/S0090-4295(96)00167-7.